Flagstaff, AZ2 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Flagstaff, AZ

Find 2 actively recruiting myalgic encephalomyelitis clinical trials in Flagstaff, AZ. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
868
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Flagstaff

About Myalgic Encephalomyelitis Clinical Trials in Flagstaff

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 2 myalgic encephalomyelitis clinical trials recruiting participants in Flagstaff, AZ. These studies are seeking a combined 868 participants. Research is being sponsored by Amgen, Northern Arizona University. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Flagstaff — FAQ

Are there myalgic encephalomyelitis clinical trials in Flagstaff?

Yes, there are 2 myalgic encephalomyelitis clinical trials currently recruiting in Flagstaff, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Flagstaff?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Flagstaff research site will contact you about next steps.

Are clinical trials in Flagstaff free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Flagstaff studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 2 active trials in Flagstaff are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 22, 2026 from ClinicalTrials.gov